{
    "nctId": "NCT00186680",
    "briefTitle": "CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant",
    "officialTitle": "Selection of CD34+THY-1 Positive Cells From Peripheral Blood Cells Procured for Autologous Hematopoietic Support Following High Dose Treatment With BCNU, Cyclophosphamide & Cisplatin for Stage IV Breast Cancer & Limited Prior Treatment",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 99,
    "primaryOutcomeMeasure": "Feasibility and safety",
    "eligibilityCriteria": "Inclusion Criteria:- stage IV breast cancer\n\n* primary breast cancer does not express CD34+\n* adequate organ function\n* no evidence of active infection Exclusion Criteria:- chemotherapy within 4 weeks\n* CNS disease",
    "sex": "ALL",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}